Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

RANK/TNFRSF11A Antibody (80704), DyLight 755, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB683Z

Catalog No. NB174329


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

RANK/TNFRSF11A Monoclonal antibody specifically detects RANK/TNFRSF11A in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA (Matched Antibody Pair)
Specifications

Specifications

RANK/TNFRSF11A
Monoclonal
DyLight 755
CD265, CD265 antigen, FEO, loss of heterozygosity, 18, chromosomal region 1, ODFROSTS, OFE, OPTB7, Osteoclast differentiation factor receptor, PDB2, RANKLOH18CR1, Receptor activator of NF-KB, receptor activator of nuclear factor-kappa B, TRANCER, tumor necrosis factor receptor superfamily member 11A, tumor necrosis factor receptor superfamily, member 11a, activator of NFKB, tumor necrosis factor receptor superfamily, member 11a, NFKB activator
Mouse myeloma cell line NS0-derived recombinant human RANK/TNFRSF11A. extracellular domain
0.5 mL
Cell Cycle and Replication
8792
Store at 4°C in the dark.
IgG1
Western Blot, Flow Cytometry, ELISA
80704
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.